IMAX Corporation IMAX
51.49 USD +0.96 (+1.90%)
Nov 4, 2026, 9:45 AM EST
51.32 Day range 51.64
32.34 52-week range 57.73
- YTD
- +39.31%
- 1 year
- +58.28%
Analyst view
Consensus: buy
Buy
Price target (mean) 60.00 +16.5% upside
Now 51.49
- Target (low)
- 52.00
- Target (mean)
- 60.00
- Target (high)
- 65.00
Ratings (0m) 12 10 buy · 2 hold · 0 sell
- Strong buy3
- Buy7
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.02 | 0.82 – 1.21 | 0.47 | +117.5% | 168.50M | +58.0% | 9 |
| Next quarter | 0.63352 | 0.42 – 0.98 | 0.58 | +9.2% | 133.28M | +6.5% | 9 |
| Current year | 2.26 | 2.03 – 2.66 | 1.45 | +55.9% | 486.19M | +18.5% | 9 |
| Next year | 2.31 | 1.92 – 2.69 | 2.26 | +2.2% | 497.69M | +2.4% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 15, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 14, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 14, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Oct 8, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | StoneX | Maintained | Buy | Buy |
| Sep 24, 2026 | Morgan Stanley | Initiated | — | Overweight |
| Sep 9, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Sep 4, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Sep 3, 2026 | Roth Capital | Maintained | Buy | Buy |
| Sep 2, 2026 | Macquarie | Maintained | Outperform | Outperform |
| Aug 24, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Aug 19, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Aug 10, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jul 24, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jul 24, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 24, 2026 | Roth Capital | Maintained | Buy | Buy |
| Jul 24, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Jul 24, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 24, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 24, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jul 20, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jul 16, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Jul 8, 2026 | Macquarie | Maintained | Outperform | Outperform |
| May 22, 2026 | Benchmark | Maintained | Buy | Buy |
| May 1, 2026 | Macquarie | Maintained | Outperform | Outperform |
| May 1, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| May 1, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 23, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Apr 20, 2026 | Rosenblatt | Maintained | Buy | Buy |